Uthaug MV

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Universiteitssingel 40, Maastricht, 6229 ER, The Netherlands. malin.uthaug@maastrichtuniversity.nl.

15 papers · 1 preprint · ORCID

ArticleDMT

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

Europe PMC2026
ArticleDMT

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Timmermann C, Sanders JW, Reydellet D +16

Europe PMC2025
ArticlePsilocybin

Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.

Tunstad PA, Kvam TM, Uthaug MV +3

Europe PMC2025
ArticlePsilocybin

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.

Kvam TM, Uthaug MV, Andersen KAA +5

Europe PMC2023
ArticleDMT

Psychological and physiological effects of extended DMT.

Luan LX, Eckernäs E, Ashton M +10

Europe PMC2024
ArticlePsilocybin

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

Kiraga MK, Kuypers KPC, Uthaug MV +2

Europe PMC2022
ArticleDMT

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).

Reckweg JT, Uthaug MV, Szabo A +4

Europe PMC2022
PreprintPsilocybin

Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees

Kiraga M, Kuypers KPC, Uthaug MV +2

Europe PMC2022
ArticlePsilocybin

<sup>1</sup>H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Vilca-Melendez S, Uthaug MV, Griffin JL

Europe PMC2021
ArticleAyahuasca

Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being.

Kiraga MK, Mason NL, Uthaug MV +4

Europe PMC2021
ArticleMescaline

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Uthaug MV, Davis AK, Haas TF +5

Europe PMC2022
ArticleMescaline

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

Agin-Liebes G, Haas TF, Lancelotta R +3

Europe PMC2021
ArticleAyahuasca

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.

Uthaug MV, Mason NL, Toennes SW +6

Europe PMC2021
ArticleDMT

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

Europe PMC2020
ArticleDMT

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.

Uthaug MV, Lancelotta R, van Oorsouw K +10

Europe PMC2019
ArticleAyahuasca

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.

Uthaug MV, van Oorsouw K, Kuypers KPC +6

Europe PMC2018